57 percent reduction in infection rate
Researchers point to a future without pacemaker battery replacements
More research needed for FDA approval
Cybersecurity concerns and physician disinterest needs to be addressed
Government group weighs in on 'advancing high-value imaging'
A look at Rep. Tom Price's advocacy track record
Quality of care wasn't compromised
Jury award reduced from $1 billion to $500 million
Drastic reductions in prostate, breast, lung and colorectal cancer mortality
Goal is to cut down on operating losses and save about $120 million
The same thing that gives them their bite may also inhibit breast cancer growth
NIH awards $5 million grant
Patient-specific model mimics physiology of artificial valve pressure response
Alleges company violated antitrust regulations
Has the potential to prevent vision loss
Patient a day late for appointment tips off researchers
But a trend toward patient access to reports and face time is emerging
Creating a smaller, more affordable proton solution
Combined portfolio expected to hit $8.7 billion in sales annually
'Annual screening of women over 40 is the way to save the most lives'
Possible flaw in reimbursement model outlined
Appoints new CEO of McKesson Canada
Breast cancer targeting probes are showing promise in clinical trials
Shares have fallen 40 percent since Tuesday
Noninvasive technology examines tau proteins
Delivering blood to newborns and their mothers in remote regions
The arsenal for fighting HAIs has grown increasingly sophisticated
Tumors emit more acidic pH than surrounding tissue
Patients are either too well or too sick to benefit
There was no shortage of major headlines this year, here are some of the biggest
Combined with cognitive assessment, the sniff test improves presymptomatic detection
Almost $1 billion in penalties since 2012
A few of the individuals who earned high praise this year
Providers search for a balance between improving efficiency and not compromising patient care
Neurosurgical is the largest segment
Know what to do before and after a critical event to minimize losses
How Dr. William DeVries and Dr. Barney Clark made history
The 10-year deal is worth EUR 74 million
GE developing THK-5351 for tau detection
Will be completed after separation of Varex and Varian